The landscape of weight loss management has changed over the years, with GLP1 agonists playing a significant role in the non-surgical management of weight loss. Join us on the 19th February for an update on the impact that GLP1s are having on diabetes, sleep apnoea, cardiovascular health and what the role of surgery is in 2026. We are looking forward to hearing how our experts: Associate Professor Spiros Fourlanos, Dr Vicki Pandeli, Dr George Kalogeropoulos and Dr Billy Stoupas, are navigating weight loss management in today’s world.
